Ovid Therapeutics, Inc. (OVID)
2.20
-0.14
(-5.98%)
USD |
NASDAQ |
Nov 20, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Price to Book Value : 2.090 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 2.090 |
| November 19, 2026 | 2.223 |
| November 18, 2026 | 2.147 |
| November 17, 2026 | 2.109 |
| November 16, 2026 | 2.280 |
| November 13, 2026 | 2.413 |
| November 12, 2026 | 2.422 |
| November 11, 2026 | 2.641 |
| November 10, 2026 | 2.660 |
| November 09, 2026 | 2.707 |
| November 06, 2026 | 2.707 |
| November 05, 2026 | 2.451 |
| November 04, 2026 | 2.603 |
| November 03, 2026 | 2.280 |
| November 02, 2026 | 2.270 |
| October 30, 2026 | 2.413 |
| October 29, 2026 | 2.432 |
| October 28, 2026 | 2.327 |
| October 27, 2026 | 2.147 |
| October 26, 2026 | 2.047 |
| October 23, 2026 | 2.052 |
| October 22, 2026 | 2.251 |
| October 21, 2026 | 2.346 |
| October 20, 2026 | 2.242 |
| October 19, 2026 | 2.061 |
| Date | Value |
|---|---|
| October 16, 2026 | 2.042 |
| October 15, 2026 | 2.147 |
| October 14, 2026 | 2.080 |
| October 13, 2026 | 2.080 |
| October 12, 2026 | 2.289 |
| October 09, 2026 | 2.337 |
| October 08, 2026 | 2.223 |
| October 07, 2026 | 2.242 |
| October 06, 2026 | 2.251 |
| October 05, 2026 | 2.223 |
| October 02, 2026 | 2.261 |
| October 01, 2026 | 2.308 |
| September 30, 2026 | 2.365 |
| September 29, 2026 | 2.236 |
| September 28, 2026 | 2.165 |
| September 25, 2026 | 2.113 |
| September 24, 2026 | 2.196 |
| September 23, 2026 | 2.262 |
| September 22, 2026 | 2.430 |
| September 21, 2026 | 2.386 |
| September 18, 2026 | 2.368 |
| September 17, 2026 | 2.377 |
| September 16, 2026 | 2.359 |
| September 15, 2026 | 2.386 |
| September 14, 2026 | 2.412 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| PS Ratio | 234.37 |
| Price | 2.20 |
| Earnings Yield | -8.40% |
| Market Cap | 415.19M |